AxoGen's Positive Investment Outlook Bolstered by Seasonal Revenue Growth and Upcoming Avance BLA Approval

TipRanksApr 2 03:26 ET

Axogen, Inc.'s (NASDAQ:AXGN) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 7.7% Over Last Week

Simply Wall StMar 26 07:04 ET

Express News | AxoGen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

ReutersMar 24 08:00 ET

Press Release: Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Dow JonesMar 24 08:00 ET

Lake Street Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $30

Moomoo NewsMar 18 02:33 ET · Ratings

Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup

Dow JonesMar 17 16:53 ET